BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: Gadget or magic? World J Gastroenterol 2007; 13(14): 2028-2036 [PMID: 17465443 DOI: 10.3748/wjg.v13.i14.2028]
URL: https://www.wjgnet.com/1007-9327/full/v13/i14/2028.htm
Number Citing Articles
1
Renato Tozzoli. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseasesClinical Chemistry and Laboratory Medicine 2008; 46(5) doi: 10.1515/CCLM.2008.138
2
Stepan Coufal, Natalie Galanova, Lukas Bajer, Zuzana Gajdarova, Dagmar Schierova, Zuzana Jiraskova Zakostelska, Klara Kostovcikova, Zuzana Jackova, Zuzana Stehlikova, Pavel Drastich, Helena Tlaskalova-Hogenova, Miloslav Kverka. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial ResponseCells 2019; 8(7): 719 doi: 10.3390/cells8070719
3
Sudha Anupindi, Rama Ayyala, Judith Kelsen, Petar Mamula, Kimberly E. Applegate. Evidence-Based Imaging in Pediatrics2010; : 487 doi: 10.1007/978-1-4419-0922-0_33
4
Peter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, Karoly Palatka, Zsuzsanna Vitalis, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Zsolt Barta, Winfried Stocker, Janos Papp, Gabor Veres, Maria Papp. Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD CohortInflammatory Bowel Diseases 2009; 15(3): 365 doi: 10.1002/ibd.20778
5
Giulia Roda, Alessandra Caponi, Marco Benevento, Paolo Nanni, Laura Mezzanotte, Andrea Belluzzi, Lloyd Mayer, Aldo Roda. New proteomic approaches for biomarker discovery in inflammatory bowel diseaseInflammatory Bowel Diseases 2010; 16(7): 1239 doi: 10.1002/ibd.21212
6
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel DiseasesInflammatory Bowel Diseases 2016; 22(8): 2016 doi: 10.1097/MIB.0000000000000836
7
Levent Kilic, Umut Kalyoncu, Omer Karadag, Ali Akdogan, Ismail Dogan, Sule Apras Bilgen, Sedat Kiraz, Ihsan Ertenli. Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?International Journal of Rheumatic Diseases 2016; 19(8): 814 doi: 10.1111/1756-185X.12837
8
Barry Hall, Grainne Holleran, Deirdre McNamara. Current applications and potential future role of wireless capsule technology in Crohn’s diseaseScandinavian Journal of Gastroenterology 2014; 49(11): 1275 doi: 10.3109/00365521.2014.962606
9
László Herszényi, Zsolt Tulassay. The Role of Autoantibodies in Inflammatory Bowel DiseaseDigestive Diseases 2012; 30(2): 201 doi: 10.1159/000336702
10
D. А. Kuznetsova, S. V. Lapin, O. B. Shchukina. The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review)Almanac of Clinical Medicine 2020; 48(6): 364 doi: 10.18786/2072-0505-2020-48-061
11
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs diseaseInflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
12
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approachEuropean Journal of Internal Medicine 2018; 48: 35 doi: 10.1016/j.ejim.2017.10.006
13
Michitaka Kohashi, Shin Nishiumi, Makoto Ooi, Tomoo Yoshie, Atsuki Matsubara, Makoto Suzuki, Namiko Hoshi, Koji Kamikozuru, Yoko Yokoyama, Ken Fukunaga, Shiro Nakamura, Takeshi Azuma, Masaru Yoshida. A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitisJournal of Crohn's and Colitis 2014; 8(9): 1010 doi: 10.1016/j.crohns.2014.01.024
14
Filomena Pascarella, Massimo Martinelli, Erasmo Miele, Annamaria Staiano. Novità in tema di malattie infiammatorie croniche intestinaliArea Pediatrica 2012; 13(4): 85 doi: 10.1016/j.arped.2012.10.002
15
Michael Mahler, Dimitrios P. Bogdanos, Polychronis Pavlidis, Marvin J. Fritzler, Elena Csernok, Jan Damoiseaux, Chelsea Bentow, Zakera Shums, Alastair Forbes, Gary L. Norman. PR3-ANCA: A promising biomarker for ulcerative colitis with extensive diseaseClinica Chimica Acta 2013; 424: 267 doi: 10.1016/j.cca.2013.06.005
16
Vishwajeet Singh, Dheeraj Kumar Gupta, Rahul Janak Sinha, Seema Mehrotra. Ileovesical Fistulae: A Rare Complication of Crohn DiseaseUroToday International Journal 2013; 6(02) doi: 10.3834/uij.1944-5784.2013.04.10
17
Francesca A. R. Silva, Bruno L. Rodrigues, Maria de Lourdes S. Ayrizono, Raquel F. Leal. The Immunological Basis of Inflammatory Bowel DiseaseGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2097274
18
Maria Papp, Nora Sipeki, Zsuzsanna Vitalis, Tamas Tornai, Istvan Altorjay, Istvan Tornai, Miklos Udvardy, Kai Fechner, Silvia Jacobsen, Bianca Teegen, Andrea Sumegi, Gabor Veres, Peter Laszlo Lakatos, Janos Kappelmayer, Peter Antal-Szalmas. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosisJournal of Hepatology 2013; 59(3): 457 doi: 10.1016/j.jhep.2013.04.018
19
Asher Kornbluth, David B Sachar. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters CommitteeAmerican Journal of Gastroenterology 2010; 105(3): 501 doi: 10.1038/ajg.2009.727
20
Amit Kaul, Susan Hutfless, Ling Liu, Theodore M. Bayless, Michael R. Marohn, Xuhang Li. Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysisInflammatory Bowel Diseases 2012; 18(10): 1872 doi: 10.1002/ibd.22862
21
Andrea Michielan, Daniela Basso, Matteo Martinato, Surajit Pathak, Antara Banerjee, Lydia Oliva, Mario Plebani, Giacomo Carlo Sturniolo, Renata D’Incà. Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relativesDigestive and Liver Disease 2013; 45(11): 894 doi: 10.1016/j.dld.2013.01.017
22
Sara Ashorn, Teemu Honkanen, Kaija-Leena Kolho, Merja Ashorn, Tuuli Välineva, Bo Wei, Jonathan Braun, Immo Rantala, Tiina Luukkaala, Sari Iltanen. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel diseaseInflammatory Bowel Diseases 2009; 15(2): 199 doi: 10.1002/ibd.20535
23
Ashwin N Ananthakrishnan. Personalizing therapy for inflammatory bowel diseasesExpert Review of Gastroenterology & Hepatology 2013; 7(6): 549 doi: 10.1586/17474124.2013.824693
24
Peter Laszlo Lakatos, Lajos S. Kiss, Pal Miheller. Nutritional Influences in Selected Gastrointestinal DiseasesDigestive Diseases 2011; 29(2): 154 doi: 10.1159/000323878
25
Dalin Li, Mark S. Silverberg, Talin Haritunians, Marla C. Dubinsky, Carol Landers, Joanne M. Stempak, Raquel Milgrom, Xiuqing Guo, Yii-Der Ida Chen, Jerome I. Rotter, Kent D. Taylor, Dermot P. B. McGovern, Stephan R. Targan. TNFRSF1B Is Associated with ANCA in IBDInflammatory Bowel Diseases 2016; 22(6): 1346 doi: 10.1097/MIB.0000000000000771
26
Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases2019; : 155 doi: 10.1007/978-981-13-6524-9_10
27
Chiara De Cassan, Bénédicte De Vroey, Catherine Dussault, Eric Hachulla, Sebastien Buche, Jean-Frédéric Colombel. Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's diseaseJournal of Crohn's and Colitis 2011; 5(4): 364 doi: 10.1016/j.crohns.2011.03.006
28
Mária Papp. Possible pathogenetic role of vascular, immunological and genetic factors in certain gastoenterological disordersOrvosi Hetilap 2008; 149(48): 2269 doi: 10.1556/oh.2008.28463
29
Maria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, Michael Mahler, Miguel Angel Mieses, Beatriz Castro, Montserrat Rivero, Javier Crespo, Marcos López-Hoyos. Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel DiseaseClinical Reviews in Allergy & Immunology 2013; 45(1): 109 doi: 10.1007/s12016-012-8349-4
30
Gerhard Rogler, Luc Biedermann. Clinical Utility of Biomarkers in IBDCurrent Gastroenterology Reports 2015; 17(7) doi: 10.1007/s11894-015-0449-x
31
Peter Laszlo Lakatos, Maria Papp, Florian Rieder. Serologic Antiglycan Antibodies in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology 2011; 106(3): 406 doi: 10.1038/ajg.2010.505
32
Anet A Soubières, Andrew Poullis. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 41-50 doi: 10.4292/wjgpt.v7.i1.41
33
Polychronis Pavlidis, Lars Komorowski, Bianca Teegen, Christos Liaskos, Andreas L. Koutsoumpas, Daniel S. Smyk, Carlo Perricone, Maria G. Mytilinaiou, Winfried Stocker, Alastair Forbes, Dimitrios P. Bogdanos. Diagnostic and clinical significance of Crohn’s disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodiesClinical Chemistry and Laboratory Medicine (CCLM) 2016; 54(2) doi: 10.1515/cclm-2015-0376
34
Elisabet Cantó, Carlos Zamora, Esther Garcia-Planella, Jordi Gordillo, M Angels Ortiz, Lidia Perea, Silvia Vidal. Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn’s Disease PatientsJournal of Crohn's and Colitis 2019; 13(1): 92 doi: 10.1093/ecco-jcc/jjy138
35
Davide Giuseppe Ribaldone, Selvaggia Brigo, Michela Mangia, Giorgio Maria Saracco, Marco Astegiano, Rinaldo Pellicano. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease ActivityMedicines 2020; 7(6): 33 doi: 10.3390/medicines7060033
36
Xuhang Li, Laurie Conklin, Philip Alex. New serological biomarkers of inflammatory bowel diseaseWorld Journal of Gastroenterology 2008; 14(33): 5115-5124 doi: 10.3748/wjg.14.5115
37
I. Ferrer Bradley, J. Hinojosa del Val. Definiciones, manifestaciones clínicas y diagnóstico de la enfermedad de CrohnMedicine - Programa de Formación Médica Continuada Acreditado 2012; 11(5): 257 doi: 10.1016/S0304-5412(12)70297-4
38
Wasseem Skef, Matthew J Hamilton, Thurayya Arayssi. Gastrointestinal Behçet's disease: A reviewWorld Journal of Gastroenterology 2015; 21(13): 3801-3812 doi: 10.3748/wjg.v21.i13.3801
39
Hubert de Boysson, Nicolas Martin Silva, Claire de Moreuil, Antoine Néel, Mathilde de Menthon, Olivier Meyer, David Launay, Christian Pagnoux, Loïc Guillevin, Xavier Puéchal, Boris Bienvenu, Achille Aouba. Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated VasculitisMedicine 2016; 95(11): e2957 doi: 10.1097/MD.0000000000002957
40
Sudha A. Anupindi, Rama Ayyala, Judith Kelsen, Petar Mamula, Kimberly E. Applegate. Evidence-Based Imaging2011; : 571 doi: 10.1007/978-1-4419-7777-9_35
41
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
42
Heba N. Iskandar, Matthew A. Ciorba. Biomarkers in inflammatory bowel disease: current practices and recent advancesTranslational Research 2012; 159(4): 313 doi: 10.1016/j.trsl.2012.01.001
43
Na-Young Han, Eun Hee Kim, Joon Choi, Hookeun Lee, Ki-Baik Hahm. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel diseaseJournal of Digestive Diseases 2012; 13(10): 497 doi: 10.1111/j.1751-2980.2012.00625.x
44
Omar I. Saadah, Jamil A. Al-Mughales. Pediatric Inflammatory Bowel Disease with Cytoplasmic Staining of Antineutrophil Cytoplasmic AntibodiesClinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/196012
45
Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim, Ki Baik Hahm. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?World Journal of Gastroenterology 2014; 20(37): 13466-13476 doi: 10.3748/wjg.v20.i37.13466
46
Maria Papp, Istvan Altorjay, Gabriella Lakos, Judit Tumpek, Sandor Sipka, Tamas Dinya, Karoly Palatka, Gabor Veres, Miklos Udvardy, Peter Laszlo Lakatos. Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel DiseaseClinical and Vaccine Immunology 2009; 16(4): 464 doi: 10.1128/CVI.00002-09
47
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic RelevanceFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
48
Maria Papp, Istvan Altorjay, Nir Dotan, Karoly Palatka, Ildiko Foldi, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gary L. Norman, Tamas Szamosi, Janos Papp, Peter L. Lakatos. New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD CohortThe American Journal of Gastroenterology 2008; 103(3): 665 doi: 10.1111/j.1572-0241.2007.01652.x
49
D. Mutter, L.O. Perotto. Facharztwissen Viszeral- und Allgemeinchirurgie2017; : 25 doi: 10.1007/978-3-662-48308-4_2
50
Paolo Nanni, Laura Mezzanotte, Giulia Roda, Alessandra Caponi, Fredrik Levander, Peter James, Aldo Roda. Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometryJournal of Proteomics 2009; 72(5): 865 doi: 10.1016/j.jprot.2008.12.010
51
Johannes Schulte-Pelkum, Antonella Radice, Gary L. Norman, Marcos Lόpez Hoyos, Gabriella Lakos, Carol Buchner, Lucile Musset, Makoto Miyara, Laura Stinton, Michael Mahler. Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic AntibodiesJournal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/185416
52
Maria Papp, Peter Laszlo Lakatos, Jolan Harsfalvi, Gyula Farkas, Karoly Palatka, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Ferenc Nagy, Gabor Veres, Laszlo Lakatos, Agota Kovacs, Tamas Dinya, Agnes Katalin Kocsis, Janos Papp, Istvan Altorjay. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohortHuman Immunology 2010; 71(4): 407 doi: 10.1016/j.humimm.2010.01.012
53
Na-Young Han, Wooseok Choi, Jong-Moon Park, Eun Hee Kim, Hookeun Lee, Ki-Baik Hahm. Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel diseaseJournal of Digestive Diseases 2013; 14(4): 166 doi: 10.1111/1751-2980.12035
54
Elisabetta Dal Pont, Renata D’Incà, Antonino Caruso, Giacomo Carlo Sturniolo. Non-invasive investigation in patients with inflammatory joint diseaseWorld Journal of Gastroenterology 2009; 15(20): 2463-2468 doi: 10.3748/wjg.15.2463
55
Levent Filik, Ibrahim Biyikoglu. Differentiation of Behcet’s disease from inflammatory bowel diseases: Anti-saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibodyWorld Journal of Gastroenterology 2008; 14(47): 7271-7271 doi: 10.3748/wjg.14.7271
56
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseasesOrvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
57
J.L. Mendoza, M.T. Abreu. Biological markers in inflammatory bowel disease: Practical consideration for cliniciansGastroentérologie Clinique et Biologique 2009; 33: S158 doi: 10.1016/S0399-8320(09)73151-3
58
Morten H. Vatn, Arne K. Sandvik. Inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2015; 50(6): 748 doi: 10.3109/00365521.2015.1033000
59
Naim Abu-Freha, Wafi Badarna, Ina Sigal-Batikoff, Muhammad Abu Tailakh, Ohad Etzion, Jaber Elkrinawi, Arik Segal, Alex Mushkalo, Alex Fich. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlationBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0884-x